Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Dysregulation of Hippo Signaling Pathway as a Convergent Mechanism Underlying Choroid Plexus Defects in Bipolar Disorder
Jonghun Kim, Museog Choe, Kutlu Kaya, et al.
Nature Chemical Biology
|
April 29, 2011
D-Ornithine coopts pyrrolysine biosynthesis to make and insert pyrroline-carboxy-lysine
Susan E Cellitti, Weijia Ou, Hsien-Po Chiu, et al.
Journal of Lipid Research
|
July 31, 2016
Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions
Gregory Guthrie, Madhulika Kulkarni, Hester Vlaardingerbroek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
Paul K Paik, Rachel K Kim, Linda Ahn, et al.
The Journal of Experimental Medicine
|
April 1, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response
Miho Tanaka, Lotus Lum, Kenneth H Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
Noura J Choudhury, W Victoria Lai, Alex Makhnin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer
Matthew G Fury, Eric Sherman, Donna Lisa, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Identification of a Small Molecule Compound Active against Antibiotic-Tolerant <i>Staphylococcus aureus</i> by Boosting ATP Synthesis
Ho-Ting-Venice Iu, Pak-Ming Fong, Hin-Cheung-Bill Yam, et al.
Scientific Reports
|
March 26, 2024
Evaluating and optimizing Acid-pH and Direct Lysis RNA extraction for SARS-CoV-2 RNA detection in whole saliva
Brayden LaBute, Jackie Fong, Farinaz Ziaee, et al.
Cancer Discovery
|
April 4, 2018
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i>-Rearranged Cancers
Alexander Drilon, Romel Somwar, Biju P Mangatt, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Dysregulation of Hippo Signaling Pathway as a Convergent Mechanism Underlying Choroid Plexus Defects in Bipolar Disorder
Jonghun Kim, Museog Choe, Kutlu Kaya, et al.
Nature Chemical Biology
|
April 29, 2011
D-Ornithine coopts pyrrolysine biosynthesis to make and insert pyrroline-carboxy-lysine
Susan E Cellitti, Weijia Ou, Hsien-Po Chiu, et al.
Journal of Lipid Research
|
July 31, 2016
Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions
Gregory Guthrie, Madhulika Kulkarni, Hester Vlaardingerbroek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
Paul K Paik, Rachel K Kim, Linda Ahn, et al.
The Journal of Experimental Medicine
|
April 1, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response
Miho Tanaka, Lotus Lum, Kenneth H Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
Noura J Choudhury, W Victoria Lai, Alex Makhnin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer
Matthew G Fury, Eric Sherman, Donna Lisa, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Identification of a Small Molecule Compound Active against Antibiotic-Tolerant <i>Staphylococcus aureus</i> by Boosting ATP Synthesis
Ho-Ting-Venice Iu, Pak-Ming Fong, Hin-Cheung-Bill Yam, et al.
Scientific Reports
|
March 26, 2024
Evaluating and optimizing Acid-pH and Direct Lysis RNA extraction for SARS-CoV-2 RNA detection in whole saliva
Brayden LaBute, Jackie Fong, Farinaz Ziaee, et al.
Cancer Discovery
|
April 4, 2018
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i>-Rearranged Cancers
Alexander Drilon, Romel Somwar, Biju P Mangatt, et al.
Page
of 10